Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000619923 | SCV000739922 | uncertain significance | Cardiovascular phenotype | 2024-05-01 | criteria provided, single submitter | clinical testing | The p.Y38S variant (also known as c.113A>C), located in coding exon 1 of the RAF1 gene, results from an A to C substitution at nucleotide position 113. The tyrosine at codon 38 is replaced by serine, an amino acid with dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |
Labcorp Genetics |
RCV000811009 | SCV000951252 | likely benign | RASopathy | 2023-10-29 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001813531 | SCV002060853 | uncertain significance | Noonan syndrome and Noonan-related syndrome | 2021-02-22 | criteria provided, single submitter | clinical testing |